0
0
6/14/23 at 12:21pm
Organization
Multiple Sclerosis News Today
33 words
0
Comments
Ocrevus is more effective than rituximab at reducing relapse activity of RRMS, while disability progression is comparable, a study suggests.
You are the first to view
https://multiplesclerosisnewstoday.com/news-posts/2023/06/14/ocrevus-better-rituximab-preventing-ms-relapses-study/
Create an account
or login to join the discussion